Fjs Hoogeveen, M H Blanker, Ecc Cauberg, M G Steffens
OBJECTIVES: To compare the recurrence of non-muscle invasive bladder carcinoma (NMIBC) after transurethral resection employing cystoscopy with hexaminolevulinate-based photodynamic diagnosis (PDD) or with standard white light. PATIENTS AND METHODS: We included patients with newly suspected NMIBC in this retrospective cohort study and compared those undergoing transurethral resection by white light cystoscopy (WLC) (2008-2010) and PDD (2010-2012). All patients were treated following established criteria for good quality resection...
December 6, 2023: Scandinavian Journal of Urology
Patrick Juliebø-Jones, Øyvind Ulvik, Christian Beisland, Bhaskar K Somani
OBJECTIVE: To develop a reporting checklist that serves to improve and standardise reporting in studies pertaining to paediatric percutaneous nephrolithotomy (PCNL). METHODS: Based on findings from systematic review of literature, a draft list of items was formulated. By process of review and revisions, a finalised version was established and consensus achieved. RESULTS: The finalised version of the checklist covers four main sections, which include the following areas: study details, pre-operative, operative and post-operative information...
November 21, 2023: Scandinavian Journal of Urology
Per-Uno Malmström, Gårdmark Truls
OBJECTIVES: To test the hypothesis that the Swedish national policy of abandoning testing for asymptomatic microscopic haematuria (AMH) introduced in 1999 did not adversely affect the prognosis of patients with urinary bladder cancer. Specific aims were to investigate possible effects on (1) Diagnostic delay as represented by stage distribution at diagnosis, (2) Survival and mortality trends, also in comparison to other countries and (3) National health care costs. MATERIAL AND METHODS: The design was an observational study using open sources on patients included in the Swedish National Bladder Cancer Registry 1997-2016...
November 21, 2023: Scandinavian Journal of Urology
Rolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, Johan Styrke, Ingela Franck Lissbrant, Hans Garmo, Pär Stattin
BACKGROUND: Randomised controlled trials have demonstrated prolonged survival with new upfront treatments in addition to standard androgen deprivation therapy (ADT) in men with de novo metastatic castration-sensitive prostate cancer. We describe patient characteristics, time trends and regional differences in uptake of these new treatment strategies in clinical practice. MATERIAL AND METHODS: This descriptive study consisted of men registered in the National Prostate Cancer Register of Sweden from 1 January 2018 to 31 March 2022 with de novo metastatic castration-sensitive prostate cancer defined by the presence of metastases on imaging at the time of diagnosis...
November 10, 2023: Scandinavian Journal of Urology
Christina Tanem Møller, Gunnar Tafjord, Augun Blindheim, Viktor Berge, Sophie Fosså, Bettina Kulle Andreassen
Before immunotherapy became part of the management of metastatic bladder cancer (mBC), systemic anti-cancer treatment comprised primarily of platinum-based chemotherapy. The objective of this study was to describe the characteristics, the initial management, overall survival (OS) and hospitalisations of patients with mBC before 2018 when immunotherapy for mBC was introduced in Norway.  Material and methods: It is a nationwide population-based study of primary mBC patients (diagnosed 2008-16). Descriptive statistics were applied and stratified for four initial management options (≤150 days after BC diagnosis): chemotherapy, major local treatment (cystectomy/pelvic radiotherapy), multimodal treatment (chemotherapy and local) and no anti-cancer treatment beyond transurethral resection of bladder tumour (untreated)...
November 10, 2023: Scandinavian Journal of Urology
Jesper Swärd, Karl Bohlin, Olof Henrikson, Sven Lundstam, Ralph Peeker, Anna Grenabo Bergdahl
OBJECTIVE: To evaluate the long-term efficacy of selective arterial embolisation in renal angiomyolipoma (AML), with emphasis on tumour shrinkage, potential regrowth and the necessity of supplementary procedures.  Material and methods: A retrospective review of all 58 consecutive embolisations at two institutions, between 1999 and 2018, was performed. Clinical notes, laboratory data and imaging were reviewed. RESULTS: The overall complication rate was 6.8%, with no Clavien-Dindo grades III-V complications...
October 31, 2023: Scandinavian Journal of Urology
Ola Bratt
No abstract text is available yet for this article.
September 28, 2023: Scandinavian Journal of Urology
Anna Karin Lind, Fredrik Liedberg, Firas Aljabery, Mats Bläckberg, Truls Gårdmark, Abofazl Hosseini, Tomas Jerlström, Viveka Ströck, Karin Stenzelius
OBJECTIVE: The aim of this study was to investigate health-related quality of life (HRQoL) before and 1 year after radical cystectomy in relation to age and gender. METHODS: This prospective study involves 112 men and 40 women with bladder cancer treated with radical cystectomy between 2015 and 2018. HRQoL was assessed preoperatively and 1 year post-surgery through Functional Assessment of Cancer Therapy Scale - General (FACT-G) and Functional Assessment of Cancer Therapy Scale - Vanderbilt Cystectomy Index (FACT-VCI) questionnaires...
September 21, 2023: Scandinavian Journal of Urology
Trude B Wedde, Milada C Smaastuen, Kari Vatne, Melanie Birthe Schulz-Jaavall, Sophie D Fosså, Wolfgang Lh Lilleby
BACKGROUND: There are few studies utilizing the Expanded Prostate Index Composite questionnaire-26 (EPIC-26) questionnaire to examine the long-term association between Domain Summary Scores (DSSs) and Quality of Life (QoL) after External Beam Radiation Therapy (EBRT, 3DCRT [3D conventional radiotherapy]/IMRT [intensity modulated radiation therapy]) versus EBRT combined with High-Dose-Rate Brachytherapy (BT+, 3DCRT [3D conventional radiotherapy]/IMRT). In this cross-sectional study we compare long-term adverse effects and QoL after BT+ with EBRT...
August 30, 2023: Scandinavian Journal of Urology
Mirjam Naomi Mohr, Annemarie Uhlig, Hannah Maria Ploeger, Oliver Hahn, Lutz Trojan, Mathias Reichert
OBJECTIVE: To demonstrate the surgical influence of secondary resection on sexual function in finally unilateral nerve-sparing robot- assisted laparoscopic prostatectomies (RALPs) performed with the 'neurovascular structure-adjacent frozen-section examination' (NeuroSAFE) technique by prospectively collecting EPIC-26-questionnaires. MATERIAL & METHODS: Sexual function status measured by the sexual-symptom-score (SexSS) in the EPIC-26-questionnaires was collected preoperatively and 12 months after RALP from 378 patients between 09/2019 and 04/2021...
August 28, 2023: Scandinavian Journal of Urology
Victoria K Znaider, Lauge H Mikkelsen, Christian Fuglesang S Jensen, Jens Sønksen, Steffen Heegaard
PURPOSE: To describe the epidemiologic, clinical, histopathological, and genetic features of primary mucosal melanoma of the urinary tract in a national Danish cohort with cases included from the year 1990 to 2019. MATERIAL AND METHODS: Patients of the Danish cohort were found using national databases. Only primary tumours were included in the cohort. Appropriate formalin-fixed paraffin-embedded blocks underwent next-generation sequencing. RESULTS: Eight cases of primary urinary bladder melanomas and 18 cases of primary urethral melanomas were included...
August 27, 2023: Scandinavian Journal of Urology
Fredrik Stenmark, Lars Brundin, Olof Gunnarsson, Henrik Kjölhede, Edvard Lekås, Ralph Peeker, Marianne Månsson, Jonas Richthoff, Johan Stranne
INTRODUCTION: During transurethral resection of the prostate (TURP), the most established surgical treatment of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO), the prostate can bleed profusely, bringing about anaemia and compromised oxygen delivery to the entire body. OBJECTIVE: The primary objective of this study was to assess the efficacy of mepivacaine and adrenaline (MA) injected into the prostate on bleeding. The primary endpoint was to measure blood loss per resected weight of prostate tissue...
August 24, 2023: Scandinavian Journal of Urology
John Åkerlund, Pernilla Sundqvist, Börje Ljungberg, Sven Lundstam, Ralph Peeker, Marianne Månsson, Anna Grenabo Bergdahl
OBJECTIVE: Nationwide register data provide unique opportunities for real-world assessment of complications from different surgical methods. This study aimed to assess incidence of, and predictors for, post-operative complications and to evaluate 90-day mortality  following different surgical procedures and thermal ablation for renal cell carcinoma (RCC). MATERIAL AND METHODS: All patients undergoing surgical treatment and thermal ablation for RCC in Sweden during 2015-2019 were identified from the National Swedish Kidney Cancer Register...
August 21, 2023: Scandinavian Journal of Urology
(no author information available yet)
June 7-10th, 2023 Bergen, Norway.
August 13, 2023: Scandinavian Journal of Urology
Martin Holmbom, Jon Forsberg, Mats Fredrikson, Maud Nilsson, Lennart E Nilsson, Håkan Hanberger, Anita Hällgren
BACKGROUND: Infection of the prostate gland following biopsy, usually with Escherichia coli, is a common complication, despite the use of antimicrobial prophylaxis. A fluoroquinolone (FQ) is commonly prescribed as prophylaxis. Worryingly, the rate of fluoroquinolone-resistant (FQ-R) E. coli species has been shown to be increasing. OBJECTIVE: This study aimed to identify risk factors associated with infection after transrectal ultrasound-guided prostate biopsy (TRUS-Bx)...
August 8, 2023: Scandinavian Journal of Urology
Kirsti Aas, Amir Sherif
Editorial comment to Urosymphyseal fistula after pelvic radiotherapy - an entity in patients with significant comorbidity requiring multidisciplinary management Scand J Urol. 2023.
August 7, 2023: Scandinavian Journal of Urology
Kristian Lyngholm Strand, Jan Maciej Krzak
No abstract text is available yet for this article.
July 10, 2023: Scandinavian Journal of Urology
Oscar Lilleby, Peter Meidahl Petersen, Gedske Daugaard, Katharina Anne Perell
PROBLEM: A low α/β ratio for prostate cancer (PCa) compared to surrounding normal tissue theoretically implies therapeutical advantages with hypofractionated treatment. Data from large randomised control trials (RCTs) comparing moderate hypofractionated (MHRT, 2.4-3.4 Gray/fraction (Gy/fx)) and ultra-hypofractionated (UHRT, >5 Gy/fx) with conventionally fractionated radiation therapy (CFRT, 1.8-2 Gy/fx) and the possible clinical implications have been reviewed. MATERIALS AND METHOD: We searched PubMed, Cochrane and Scopus for RCT comparing MHRT/UHRT with CFRT treatment of locally and/or locally advanced (N0M0) PCa...
June 20, 2023: Scandinavian Journal of Urology
Stefan Carlsson, David Bock, Anna Lantz, Eva Angenete, Katarina Koss Modig, Jonas Hugosson, Anders Bjartell, Gunnar Steineck, Peter Wiklund, Eva Haglind
OBJECTIVE: Radical prostatectomy reduces mortality among patients with localized prostate cancer, however up to 35% of patients will experience biochemical recurrence, often treated with salvage radiotherapy. The objective of the study was to investigate long-term effects of salvage radiotherapy. METHODS: A prospective, controlled, non-randomized trial at 14 Swedish center's including 4,003 patients scheduled for radical prostatectomy 2008-2011. A target trial emulation approach was used to identify eligible patients that was treated with salvage radiotherapy...
May 11, 2023: Scandinavian Journal of Urology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.